Blood gas and electrolyte analyzers market seen reaching $5.64 billion by 2030

The Business Research Company says the global blood gas and electrolyte analyzers market will rise from $3.98 billion in 2026 to $5.64 billion by 2030, driven by demand for faster diagnostics in emergency and intensive care settings. North America led the market in 2025, while decentralized testing and portable devices are expected to fuel the next phase of growth.

Why it matters: - Blood gas and electrolyte analyzers support clinical decisions in critical and emergency care. - Rising demand for faster and more decentralized testing could reshape how hospitals, labs and home-based care providers handle diagnostics. - The projected expansion signals continued spending on automated and point-of-care testing systems.

What happened: - The Business Research Company published a global market report on blood gas and electrolyte analyzers on November 6, 2026. - The report says the market will grow from $3.65 billion in 2025 to $3.98 billion in 2026. - The report projects the market will reach $5.64 billion by 2030, implying a 9.1% CAGR. - The release frames the market as a key part of clinical diagnostics for patient care in critical and emergency settings.

The details: - Blood gas and electrolyte analyzers measure pH levels, blood gases, electrolytes and metabolites from whole blood samples. - Electrolyte measurements are commonly performed in clinical labs using serum and whole blood samples during arterial blood gas analysis. - Historical growth has been supported by more critical care admissions, better hospital laboratory facilities, wider use of arterial blood gas testing, a higher incidence of respiratory illnesses and broader access to automated analyzers. - Looking ahead, growth is expected to come from demand for decentralized diagnostic testing, stronger focus on emergency and intensive care analysis, expansion of at-home and near-patient testing, investment in smart diagnostic technologies and wider adoption of integrated laboratory workflows. - Emerging trends include more point-of-care blood gas testing, growing use of portable and benchtop devices, multi-parameter testing platforms, cartridge-based consumables and faster diagnostic turnaround times. - The report says North America held the largest market share in 2025 and is expected to grow fastest through the forecast period. - The report also covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - Download a free sample of the report - View the full market report

Between the lines: - The growth story is less about a single device category and more about diagnostics moving closer to the patient. - Hospitals and clinics appear to be prioritizing speed, integration and portability over traditional lab-only workflows. - The patient-load example from the UK points to a broader driver: more testing volume across primary care and acute care settings. - In June 2024, the Royal College of General Practitioners in the UK reported average patient load per general practitioner rose from 2,222 in 2022 to 2,294 in April 2024.

What's next: - The market is likely to benefit from continued investment in smart analyzers and point-of-care platforms. - Device makers will probably keep pushing multi-parameter systems and cartridge-based models as buyers look for faster turnaround and simpler workflows. - Regional momentum in North America may remain strong, but the report suggests global demand is broad-based.

The bottom line: - Blood gas and electrolyte analyzers are on track for steady, high-single-digit growth as healthcare systems demand faster, more flexible diagnostics.